Cloudbreak Pharma Inc. (HKG:2592)
Hong Kong · Delayed Price · Currency is HKD 1.190
+0.025 (2.15%)
Sep 9, 2026, 6:08 PM HKT
Cloudbreak Pharma Market Cap
Cloudbreak Pharma has a market cap or net worth of 1.01 billion as of September 18, 2026. Its market cap has decreased by -76.28% in one year.
Market Cap
1.01B
Enterprise Value
703.91M
Revenue
2.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.19
ChartMarket Cap Chart
Since July 3, 2025, Cloudbreak Pharma's market cap has decreased from 5.20B to 1.01B, a decrease of -80.68%. That is a compound annual growth rate of -74.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 1.01B | -76.96% |
| Dec 31, 2025 | 4.36B | -16.13% |
| Jul 3, 2025 | 5.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SinoMab BioScience | 1.56B |
| Shandong Boan Biotechnology | 1.52B |
| Beijing Biostar Pharmaceuticals | 1.49B |
| Zhaoke Ophthalmology | 1.37B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.35B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.30B |
| TYK Medicines | 1.25B |
| CANbridge Pharmaceuticals | 1.20B |